![Marcin Gondek](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Provenance du réseau au premier degré de Marcin Gondek
Entité | Type d'entité | Industrie | |
---|---|---|---|
Synexus Clinical Research GmbH
![]() Synexus Clinical Research GmbH Miscellaneous Commercial ServicesCommercial Services Part of Thermo Fisher Scientific, Inc., Synexus Clinical Research GmbH is a clinical research organization based in Leipzig, Germany. The CEOs are Radoslaw Janiak, Marcin Gondek, Iwona Tongbhoyai. The German company was founded in 1992. Synexus Clinical Research was acquired by Synexus Clinical Research Ltd., part of Thermo Fisher Scientific, Inc. from June 08, 2016 on January 12, 2010.
2
| Subsidiary | Miscellaneous Commercial Services | 2 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Marcin Gondek via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
Synexus Clinical Research Ltd.
![]() Synexus Clinical Research Ltd. Medical/Nursing ServicesHealth Services Synexus Clinical Research Ltd. offers clinical trials and biological research services. It offers clinical trial management, project management, medical imaging and medical procedures. The company was founded in 1998 and is headquartered in Lancashire, the United Kingdom. | Medical/Nursing Services | President | |
Future Meds Ltd.
![]() Future Meds Ltd. Miscellaneous Commercial ServicesCommercial Services Future Meds Ltd. is a fast-growing independent research site network that supports pharmaceutical companies, sponsors, and CROs in finding effective treatments and medications for patients. The private company is based in Bromborough, UK, and has subsidiaries in Germany and the United Kingdom. The British company's dedicated research site teams aim to accelerate study timelines, streamline processes, lower costs, and improve data quality to help patients access new treatments faster. Future Meds is a network of modern dedicated research sites that conduct clinical trials using innovative technologies to make them available to as many patients as possible. The company was founded in 2020, and Radoslaw Janiak has been the CEO since 2019. | Miscellaneous Commercial Services | Chief Executive Officer |
Statistiques
Internationale
Royaume-Uni | 3 |
Sectorielle
Health Services | 2 |
Commercial Services | 2 |
Opérationnelle
Chief Executive Officer | 3 |
Chief Operating Officer | 1 |
Corporate Officer/Principal | 1 |
President | 1 |
Relations les plus connectées
Insiders | |
---|---|
Radoslaw Janiak | 3 |
Iwona Tongbhoyai | 1 |
- Bourse
- Insiders
- Marcin Gondek
- Connexions Sociétés